Veeva Systems Inc. (0LO3.L)
USD 226.24
(1.17%)
USD 226.24
(1.17%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 5.91 Billion USD | 23.03% |
| 2023 | 4.8 Billion USD | 25.88% |
| 2022 | 3.81 Billion USD | 25.29% |
| 2021 | 3.04 Billion USD | 34.08% |
| 2020 | 2.27 Billion USD | 37.37% |
| 2019 | 1.65 Billion USD | 37.76% |
| 2018 | 1.2 Billion USD | 30.81% |
| 2017 | 917.7 Million USD | 30.02% |
| 2016 | 705.79 Million USD | 29.53% |
| 2015 | 544.89 Million USD | 47.15% |
| 2014 | 370.3 Million USD | 312.28% |
| 2013 | 89.82 Million USD | 116.88% |
| 2012 | 41.41 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 5.91 Billion USD | 13.11% |
| 2024 Q3 | 5.22 Billion USD | -0.05% |
| 2024 Q1 | 5.02 Billion USD | 4.56% |
| 2024 FY | 5.91 Billion USD | 23.03% |
| 2024 Q2 | 5.22 Billion USD | 4.08% |
| 2023 Q2 | 4.11 Billion USD | 2.63% |
| 2023 Q3 | 4.18 Billion USD | 1.61% |
| 2023 FY | 4.8 Billion USD | 25.88% |
| 2023 Q1 | 4.01 Billion USD | 5.1% |
| 2023 Q4 | 4.8 Billion USD | 14.86% |
| 2022 Q2 | 3.35 Billion USD | 4.01% |
| 2022 Q1 | 3.22 Billion USD | 5.78% |
| 2022 FY | 3.81 Billion USD | 25.29% |
| 2022 Q4 | 3.81 Billion USD | 13.33% |
| 2022 Q3 | 3.36 Billion USD | 0.48% |
| 2021 Q1 | 2.4 Billion USD | 5.85% |
| 2021 FY | 3.04 Billion USD | 34.08% |
| 2021 Q4 | 3.04 Billion USD | 17.9% |
| 2021 Q2 | 2.51 Billion USD | 4.65% |
| 2021 Q3 | 2.58 Billion USD | 2.67% |
| 2020 Q4 | 2.27 Billion USD | 19.54% |
| 2020 Q1 | 1.77 Billion USD | 7.4% |
| 2020 FY | 2.27 Billion USD | 37.37% |
| 2020 Q2 | 1.85 Billion USD | 4.72% |
| 2020 Q3 | 1.9 Billion USD | 2.18% |
| 2019 Q3 | 1.39 Billion USD | 2.4% |
| 2019 FY | 1.65 Billion USD | 37.76% |
| 2019 Q4 | 1.65 Billion USD | 18.36% |
| 2019 Q2 | 1.36 Billion USD | 3.56% |
| 2019 Q1 | 1.31 Billion USD | 9.76% |
| 2018 Q2 | 1.03 Billion USD | 3.98% |
| 2018 Q4 | 1.2 Billion USD | 14.75% |
| 2018 Q1 | 996.19 Million USD | 8.55% |
| 2018 FY | 1.2 Billion USD | 30.81% |
| 2018 Q3 | 1.04 Billion USD | 1.0% |
| 2017 Q2 | 787.23 Million USD | 4.71% |
| 2017 Q4 | 917.7 Million USD | 16.39% |
| 2017 FY | 917.7 Million USD | 30.02% |
| 2017 Q1 | 751.79 Million USD | 6.52% |
| 2017 Q3 | 788.47 Million USD | 0.16% |
| 2016 FY | 705.79 Million USD | 29.53% |
| 2016 Q2 | 591.63 Million USD | 4.04% |
| 2016 Q4 | 705.79 Million USD | 12.92% |
| 2016 Q3 | 625.03 Million USD | 5.65% |
| 2016 Q1 | 568.66 Million USD | 4.36% |
| 2015 FY | 544.89 Million USD | 47.15% |
| 2015 Q4 | 544.89 Million USD | 10.63% |
| 2015 Q3 | 492.55 Million USD | 6.1% |
| 2015 Q2 | 464.24 Million USD | 6.69% |
| 2015 Q1 | 435.12 Million USD | 17.5% |
| 2014 FY | 370.3 Million USD | 312.28% |
| 2014 Q4 | 370.3 Million USD | 7.25% |
| 2014 Q3 | 345.28 Million USD | 206.6% |
| 2014 Q2 | 112.62 Million USD | 8.94% |
| 2014 Q1 | 103.38 Million USD | 15.1% |
| 2013 Q4 | 89.82 Million USD | 0.0% |
| 2013 FY | 89.82 Million USD | 116.88% |
| 2012 FY | 41.41 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -1492.875% |
| Accuray Incorporated | 468.62 Million USD | -1161.327% |
| Align Technology, Inc. | 6.08 Billion USD | 2.843% |
| Elevance Health Inc. | 108.92 Billion USD | 94.574% |
| AxoGen, Inc. | 196.82 Million USD | -2903.104% |
| Boston Scientific Corporation | 35.13 Billion USD | 83.177% |
| CVS Health Corporation | 249.72 Billion USD | 97.633% |
| Cardinal Health, Inc. | 45.12 Billion USD | 86.9% |
| Centene Corporation | 84.64 Billion USD | 93.016% |
| DaVita Inc. | 17.61 Billion USD | 66.452% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 89.484% |
| Hologic, Inc. | 9.15 Billion USD | 35.442% |
| Humana Inc. | 47.06 Billion USD | 87.441% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -81.321% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 64.658% |
| Masimo Corporation | 3.04 Billion USD | -94.342% |
| McKesson Corporation | 67.44 Billion USD | 91.236% |
| Patterson Companies, Inc. | 2.96 Billion USD | -99.084% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | 57.845% |
| ResMed Inc. | 6.87 Billion USD | 13.99% |
| Henry Schein, Inc. | 10.57 Billion USD | 44.094% |
| Teladoc Health, Inc. | 4.39 Billion USD | -34.572% |
| Universal Health Services, Inc. | 14.35 Billion USD | 58.829% |
| Baxter International Inc. | 28.27 Billion USD | 79.096% |
| Becton, Dickinson and Company | 52.78 Billion USD | 88.801% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 61.721% |
| Danaher Corporation | 84.48 Billion USD | 93.004% |
| Stryker Corporation | 39.91 Billion USD | 85.19% |
| Medtronic plc | 89.98 Billion USD | 93.431% |